Loading clinical trials...
Loading clinical trials...
Randomized Phase II Trial of Preoperative Combined Modality Chemoradiation for Distal Rectal Cancer
Conditions
Interventions
fluorouracil
irinotecan hydrochloride
+2 more
Locations
235
United States
University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, Alabama, United States
Comprehensive Cancer Institute of Huntsville
Huntsville, Alabama, United States
Huntsville Hospital System
Huntsville, Alabama, United States
MBCCOP - Gulf Coast
Mobile, Alabama, United States
Alabama Oncology, LLC
Montgomery, Alabama, United States
Radiation Oncology Associates of West Alabama
Tuscaloosa, Alabama, United States
Start Date
February 1, 2001
Primary Completion Date
December 1, 2003
Last Updated
October 22, 2020
NCT07446322
NCT07541924
NCT04693377
NCT07529301
NCT07416552
NCT07276529
Lead Sponsor
Radiation Therapy Oncology Group
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions